There are 2789 resources available
1286P - Senescent immune phenotype (SIP) status predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients
Presenter: Marie Naigeon
Session: ePoster Display
1332P - A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Presenter: Susumu Takeuchi
Session: ePoster Display
1288P - Mutations in MTOR pathway and response of immune checkpoint inhibitors
Presenter: Lei Cheng
Session: ePoster Display
Resources:
Abstract
1289P - Intracranial response (ICR) following immunotherapy in non-small cell lung cancer (NSCLC) patients with untreated brain metastasis (BM)
Presenter: Birgitte Bjoernhart
Session: ePoster Display
1396P - Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: An exploratory analysis from the PRODIGY study
Presenter: Hyung-don Kim
Session: ePoster Display
1398P - The impact of personalized prehabilitation on tolerance to chemotherapy in patients with gastric and oesophageal cancer. A controlled study
Presenter: Grigorios Christodoulidis
Session: ePoster Display